Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica.
Okada
Kazumasa
K
Department of Neurology, University of Occupational and Environmental Health, Kitakyushu. gion@med.uoeh-u.ac.jp
Tsuji
Sadatoshi
S
Tanaka
Keiko
K
D000328:Adult; D051401:Aquaporin 4 / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009471:Neuromyelitis Optica / Q000517:prevention & control*; D055502:Secondary Prevention
C496030:AQP4 protein, human; D051401:Aquaporin 4; D016756:Immunoglobulins, Intravenous